While commissioners and services have to consider cost when initiating people on #LAIB, we propose that the wider economic benefits to the individual and health care services should be considered along with cost to improve outcomes for people with OUD and reduce health inequalities (3/3)

With our partners Via we compared outcomes for Long-Acting Injectable Buprenorphine #LAIB to standard medication & found improved quality of life, mental health and physical health. Our analyses, published in BMJ Open, provide evidence that LAIB is associated with improved outcomes (2/3)

While #methadone & SL #Buprenorphine are standard pharmacological treatment for #opioid use disorder, novel longer-acting formulations can improve treatment outcomes. Yet people with OUD cannot always access these treatments due to cost & availability (1/3)

bmjopen.bmj.com/content/15/2...

t.co/tMkBalHeZE

@thepandemicinst.bsky.social
@ljmuimpact.bsky.social
@ljmuofficial.bsky.social
@annapowellphd.bsky.social

(3/3)

Our analysis, published today in @Els_Vaccine found that #deprivation, age, sex, and ethnicity influence influenza vaccine uptake. In areas of high deprivation like Liverpool, #inequality impairs health outcomes for all citizens and requires targeted intervention (2/3)

In January 2025 @nhsUHLG declared a critical incident due to pressures of #flu and #respiratory illness in #Liverpool. #vaccinations can reduce #influenza severity, yet rates remain low. We analysed sociodemographic factors related to #vaccine uptake (1/3)